News & Blog

Tag Archives: FDA

Creating Meaningful Change, With a Little Help From our Friends

There are only four FDA-approved therapies to treat brain tumors. And in the last 17 years there have been approximately 75 potential new drugs that have failed during the clinical trial process to prove they are safe and effective for patients, while only three that have won FDA approval[1]. That is a 25:1 failure ratio. […]

Making Sense of Project Impact: Preclinical testing

As part of our effort to raise awareness during Childhood Cancer Awareness Month, we created an infographic about our newest initiative that aims to get new and better treatments to children with brain tumors – Project Impact. Today, we want to spend some time talking about a major piece of that initiative, the so-called “preclinical […]

The (Critical) Case for Pediatric Brain Tumor & Cancer Advocacy

National Brain Tumor Society is one of many disease-based organizations to join the chorus of supporters of stronger funding for the National Institutes of Health (NIH). The agency – through the National Cancer Institute (NCI) and other institutes – is the largest funder of brain tumor research in the country. Dwindling investment in this agency […]

Share